Pharmaceutical Outsourcing Company Focus: A Russell Publishing Publication
CoreRx Inc.
6101 Johns Rd
Tampa, FL  33634
USA

Tel: 813 514 9399
Fax: 813 514 9401
EMail: info@corerxpharma.com
Visit our website at: www.corerxpharma.com

COMPANY DESCRIPTION

CoreRx™ is a contract pharmaceutical development organization offering comprehensive early drug product development services to the pharmaceutical and biotechnology industries. Supporting virtual, mid-size, and multinational companies, CoreRx™ offers customized formulation development and clinical material manufacturing solutions.

Our development solutions optimize client investments, shorten development time and reduce overall costs. From first-in-man drug development to full cGMP manufacturing support, CoreRx™ combines 200+ years of combined pharmaceutical development expertise to produce safe, effective, and innovative drug products, on time, and on budget.





COMPANY BACKGROUND


CoreRx™, was founded in 2006 in attempt to address the growing industry needs for scientific depth, scientist-to-scientist communication, and dependability. The CoreRx management team combines big pharma experience with years of contract drug development. We understand your outsourcing concerns and challenges.

FACILITIES

Our facility in Tampa, Florida is FDA and Florida Department of Health registered and DEA approved (schedules II – V of controlled drugs).

SERVICES & CAPABILITIES

CoreRx™ offers complete contract drug development support and analysis, from formulation feasibility studies for proof-of-principal, to excipient compatibility
evaluation, final product formulation optimization, cGMP clinical batch manufacture and complete analytical testing. Additionally, CoreRx™ has the facilities and expertise to work on the most challenging drug formulation issues, including solubility concerns, unstable compounds, innovative delivery options, low
dose formulations, controlled drugs, and cytotoxic/high potency compounds.

Our Services Include:
• First-in-man development (API in capsule/bottle)
• NDA and ANDA Product development
• Development of Sustained Release dosage forms
• Fixed dosage combination product development (tri-layer tablets)
• Cytotoxic/Potent Compound Development
• Feasibility Studies to assist in dosage form selection
• Compatibility studies
• Formulation optimization
• Taste masking/flavoring
• Full Analytical Development
• Stability Studies (short & long term)
• cGMP Clinical Manufacturing & Packaging

Product Expertise
CoreRx™ scientists have formulation development, analytical, and clinical trial material (CTM) manufacturing expertise in a wide array of dosage forms.

Oral
• Capsules
• Tablets
• Fast Dissolve Tablets (ODT)
• Solutions
• Suspensions

Parenteral
• Solutions
• Suspensions
• Emulsions

Opthalmics
• Solutions
• Suspensions
• Ointments

Topical
• Gels
• Creams
• Ointments
• Lotions

Combination Products
• Fixed Dosage Combination Tri-layer tablets
• Multi-particulate drug delivery

Cytoxic and Potent Drugs
• Preclinical toxicology supplies
• Prototype development
• Phase I/II clinical supplies